• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGT2815
Device Problems Degraded (1153); Material Rupture (1546)
Patient Problems Death (1802); Unspecified Infection (1930)
Event Date 04/21/2010
Event Type  Injury  
Event Description
On (b)(6) 2010, the patient underwent an open abdominal surgery to place a bypass from the abdominal aorta to the abdominal aortic branches (superior mesenteric artery and left renal artery) which would be covered by a gore® tag® thoracic endoprosthesis in the following procedure.It was reported that a saphenous vein graft (svg)was used for the bypass of sma.On (b)(6) 2010, the patient underwent endovascular repair of a thoraco abdominal aortic aneurysm using a gore® tag® thoracic endoprosthesis and a non-gore manufactured stent graft.On unknown date, the patient presented with the ruptured svg used to bypass the sma and the device infection.The patient underwent retroperitoneal drainage, surgical hemostasis of the ruptured svg, antibiotic medication, and dialysis.On (b)(6) 2010, the patient expired due to infection.It was reported that the physician believes the infection was due to the surgical bypass performed on the abdominal aortic branches prior to the implantation of the devices.It was also reported that the rupture of the svg was due to the deterioration of the svg due to infection.
 
Manufacturer Narrative
A review of the manufacturing and sterilization paperwork for the devices verified that the lots met all pre-release specifications.Per the gore® tag® thoracic endoprosthesis instructions for use (ifu), complications associated with the use of the gore® tag® thoracic endoprosthesis may include but are not limited to infection and death.
 
Manufacturer Narrative
Corrected the implant date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
kanae rikimaru
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4120332
MDR Text Key20322070
Report Number2017233-2014-00503
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/27/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/26/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2013
Device Catalogue NumberTGT2815
Device Lot Number7583167
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age70 YR
Patient Weight68
-
-